Mereo BioPharma MREO Balance Sheet (2017-2026)

NASDAQ MREO
$0.29 -0.02 (-6.45%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2017 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation (Quarter)
0.74M0.80M0.84M0.88M0.96M0.95M1.02M1.11M1.05M1.08M0.98M1.02M
Assets
Current Assets
Cash & Equivalents (Quarter)
70.55M30.99M153.88M127.11M96.23M66.08M52.70M57.42M48.70M87.43M80.52M69.80M62.50M56.12M48.70M40.99M36.22M30.12M
Receivables - Net (Quarter)
0.89M9.88M
Receivables - Other (Quarter)
2.28M0.85M1.44M1.91M1.27M0.89M1.95M
Receivables (Quarter)
1.79M9.88M
Prepaid Assets (Quarter)
1.74M2.14M6.18M3.77M3.45M3.67M1.72M5.16M3.19M4.49M3.83M2.17M2.52M2.54M2.69M2.53M2.25M1.60M
Current Assets (Quarter)
82.80M39.25M168.20M133.89M103.02M72.88M67.86M63.76M53.50M93.94M86.72M74.76M66.90M61.42M52.41M45.02M40.03M33.40M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
53.52M2.08M34.36M36.52M33.03M30.43M33.05M0.41M0.36M0.34M0.32M0.26M0.25M0.22M0.17M0.14M0.09M0.05M
Intangibles (Quarter)
39.58M43.58M31.02M33.11M30.37M28.29M31.09M1.09M0.97M0.87M0.80M0.64M0.55M0.47M0.64M0.52M0.38M0.26M
Goodwill & Intangibles (Quarter)
39.58M43.58M31.02M33.11M30.37M28.29M31.09M1.09M0.97M0.87M0.80M0.64M0.55M0.47M0.64M0.52M0.38M0.26M
Other Non-Current Assets (Quarter)
0.61M0.47M0.44M0.38M0.38M0.40M0.39M0.40M0.39M0.39M
Non-Current Assets (Quarter)
53.52M-39.25M-168.20M-133.89M-103.02M-72.88M-67.86M2.74M2.44M2.19M2.02M1.63M1.42M1.21M1.20M0.90M0.58M1.31M
Assets (Quarter)
136.32M66.50M55.94M96.13M88.75M76.39M68.32M62.63M53.60M45.92M40.61M34.71M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
6.82M4.40M3.06M3.37M3.55M3.61M2.39M2.35M2.46M2.70M1.75M2.44M2.92M1.14M0.88M1.33M3.23M1.12M
Notes Payables (Quarter)
16.46M13.00M5.24M4.63M4.93M5.55M5.54M
Payables (Quarter)
23.27M4.40M3.06M3.37M3.55M16.61M7.63M2.35M7.08M7.63M7.30M7.97M2.92M1.14M0.88M1.33M3.23M1.12M
Accumulated Expenses (Quarter)
5.44M5.47M2.54M3.72M3.53M4.07M2.93M5.04M4.12M2.03M2.05M2.46M
Other Accumulated Expenses (Quarter)
1.07M1.02M0.72M3.44M2.64M1.09M0.89M0.78M0.62M0.74M0.91M1.07M
Short term Debt (Quarter)
16.46M20.09M13.00M5.24M
Current Leases (Quarter)
1.11M0.84M1.01M0.84M0.73M0.55M0.61M0.65M0.66M0.68M0.74M0.71M0.75M0.60M0.40M0.20M1.03M
Current Taxes (Quarter)
2.05M
Total Current Liabilities (Quarter)
27.69M11.31M13.80M16.91M44.34M28.94M21.85M9.49M11.00M15.47M14.21M13.85M7.50M7.56M6.02M4.30M6.18M5.68M
Non-Current Liabilities
Non-Current Debt (Quarter)
18.01M21.31M25.07M19.39M4.59M
Convertible Debt (Quarter)
4.39M
Operating Leases (Quarter)
13.87M1.53M2.73M2.36M1.83M1.43M1.22M0.91M1.39M0.55M0.39M0.19M
Other Non-Current Liabilities (Quarter)
44.40M67.05M47.54M11.24M8.97M0.62M0.51M0.76M0.85M0.93M1.04M0.82M0.42M0.55M0.65M0.66M0.36M0.37M
Total Non-Current Liabilities (Quarter)
78.44M91.58M75.99M34.88M4.09M1.80M6.80M15.20M12.24M16.55M15.17M14.60M7.82M7.91M6.35M4.34M6.20M5.69M
Total Liabilities (Quarter)
106.21M102.89M89.78M51.78M48.42M30.74M28.65M15.96M13.10M17.48M16.21M15.42M8.24M8.45M7.00M5.00M6.56M6.06M
Shareholder's Equity
Total Debt (Quarter)
34.47M21.31M25.07M19.39M20.09M13.00M9.82M
Common Equity (Quarter)
-19.77M112.77M118.63M87.63M72.57M44.40M49.66M54.71M50.54M42.84M78.65M-72.54M60.97M60.08M54.18M46.60M40.92M34.05M28.65M
Liabilities and Shareholders Equity (Quarter)
136.32M66.50M55.94M96.13M88.75M76.39M68.32M62.63M53.60M45.92M40.61M34.71M
Treasury Shares (Quarter)
19.50M0.41M0.92M1.34M0.86M0.86M0.86M0.98M0.98M0.98M0.98M1.64M1.55M
Retained Earnings (Quarter)
158.60M-408.93M181.74M175.02M166.57M-388.43M-428.21M486.11M486.93M534.73M536.43M539.64M544.27M546.33M548.04M549.62M551.02M552.34M